Product Information
DIMETHYL FUMARATE DR 240 MG CP is a generic product labeled by Ascend Laboratories, LLC, priced at $0.4672 per EA under NDC 67877055660. Its NADAC has been published 259 times since Oct 20, 2021.
FDA first approved this application on Sep 24, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
240 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877055660
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DIMETHYL FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA210440FDA Approved
9/24/2020
TE Code
AB
On Market Since
9/26/2020
Price Statistics
The NADAC for DIMETHYL FUMARATE DR 240 MG CP has been published 259 times since Oct 20, 2021, and over the history we have for it it has declined 90.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4672 per EA |
|---|---|
| All-time high | $4.7614 (Nov 10, 2021) |
| All-time low | $0.4223 (Jul 22, 2026) |
| 52-week high | $0.8188 |
| 52-week low | $0.4223 |
| Median price | $0.9841 |
| Average price | $1.4051 |
| Largest weekly change | +85.3% (Dec 20, 2023) |
| Weeks tracked | 259 |
| Tracking since | Oct 20, 2021 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ascend Laboratories, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dimethyl fumarate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DIMETHYL FUMARATE DR 240 MG CP?
The current National Average Drug Acquisition Cost (NADAC) for DIMETHYL FUMARATE DR 240 MG CP, manufactured by Ascend Laboratories, LLC, is $0.4672 per EA (NDC 67877055660), effective Sep 30, 2026.
How has the price of DIMETHYL FUMARATE DR 240 MG CP changed over time?
Over the history we have for it, the NADAC for DIMETHYL FUMARATE DR 240 MG CP has declined 90.2%. It has been tracked across 259 weekly CMS publications since Oct 20, 2021.
What are the highest and lowest recorded NADAC prices for DIMETHYL FUMARATE DR 240 MG CP?
Since Oct 20, 2021, the NADAC for DIMETHYL FUMARATE DR 240 MG CP has ranged from a low of $0.4223 (Jul 22, 2026) to a high of $4.7614 (Nov 10, 2021), with a median of $0.9841 per EA.
Are there cheaper alternatives to DIMETHYL FUMARATE DR 240 MG CP?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DIMETHYL FUMARATE DR 240 MG CP, is $0.4555 per EA — about 2% below DIMETHYL FUMARATE DR 240 MG CP.
Who manufactures DIMETHYL FUMARATE DR 240 MG CP?
DIMETHYL FUMARATE DR 240 MG CP (NDC 67877055660) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.